Cargando…
Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology
Hyperkalemia (HK) is the most common electrolyte disturbance observed in patients with kidney disease, particularly in those in whom diabetes and heart failure are present or are on treatment with renin–angiotensin–aldosterone system inhibitors (RAASIs). HK is recognised as a major risk of potential...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588653/ https://www.ncbi.nlm.nih.gov/pubmed/31119681 http://dx.doi.org/10.1007/s40620-019-00617-y |